In this study, we report the cloning and characterization of a novel human Ste20-related kinase that we designated MST4 (accession number AF231012). The 416 amino acid full-length MST4 contains an aminoterminal kinase domain, which is highly homologous to MST3 and SOK, and a unique carboxy-terminal domain. Northern blot analysis indicated that MST4 is highly expressed in placenta, thymus, and peripheral blood leukocytes. Wild-type but not kinase-dead MST4 can phosphorylate myelin basic protein in an in vitro kinase assay. MST4 speci®cally activates ERK but not JNK or p38 MAPK in transient transfected cells or in stable cell lines. Overexpression of dominant negative MEK1 or treatment with PD98059 abolishes MST4-induced ERK activity, whereas dominant-negative Ras or c-Raf-1 mutants failed to do so, indicating MST4 activates MEK1/ERK via a Ras/Raf-1 independent pathway. HeLa and Phoenix cell lines overexpressing wild-type, but not kinase-dead, MST4 exhibit increased growth rate and form aggressive soft-agar colonies. These phenotypes can be inhibited by PD98059. These results provide the ®rst evidence that MST4 is biologically active in the activation of MEK/ERK pathway and in mediating cell growth and transformation. Oncogene (2001) 20, 6559 ± 6569.
Introduction
The Sterile-20 (Ste20) protein kinase was ®rst identi®ed as a crucial factor involved in pheromone signaling pathway in Saccharomyces cerevisiae (Leberer et al., 1992) . Genetic epistasis analysis has placed Ste20 kinase between the heterotrimeric G protein (Gilbreth et al., 1996; Mosch et al., 1996) , which is activated by pheromone exposure, and the MAPK cassette (Mosch et al., 1996; Raitt et al., 2000) . Ste20 activates the MAPK cascade which includes Ste11 (MAPK kinase kinase) Lee and Elion, 1999) , Ste7 (MAPK kinase) (Leberer et al., 1996) and FUS3/KSS1 (MAPK) Schrick et al., 1997) in yeast. Several serine/threonine protein kinases related to the Ste20 protein kinase have been recently identi®ed in mammalian cells. Based on the relative location of the kinase catalytic domain and the ability to bind small G-proteins, these mammalian Ste20 related protein kinases can be broadly divided into two subfamilies.
The ®rst subfamily contains a C-terminal catalytic domain and an N-terminal Cdc42/Rac1 interactive binding (CRIB) motif (Osada et al., 1997) . The yeast Ste20 kinase and its mammalian homolog, p21-activated kinase 1 (PAK1), belong to this class . The PAK kinases have been implicated in activating the stress-activated protein kinase (SAPK)/ Jun N-terminal kinase (JNK) pathway as well as in regulating the actin cytoskeleton and cell mobility Pombo et al., 1996) . The second subfamily of Ste20s is represented by the germinal center kinase (GCK) which contains an N-terminal catalytic domain with a C-terminal regulatory domain (Dan et al., 2000; Fu et al., 1999) . This class of kinases lacks a recognizable CRIB motif and thus cannot be activated by Cdc42/Rac1. Like, PAK, many of the GCK class members activate JNK. For instance, GCK, GCK-related (GCKR) (Shi et al., 2000) , hematopoietic progenitor kinase 1 (HPK1) Oehrl et al., 1998; Zhou et al., 1999) , kinase homologous to Ste20/Sps1p kinase (KHS) (Oehrl et al., 1998; Tung and Blenis, 1997) , Mammalian Sterile Twenty-like (MST1) (Graves et al., 1998) , Nck-interacting kinase (NIK) (Su et al., 1997) , HPK/GCK-like kinase (HGK) , Traf2-and Nck-interacting kinase (TNIK) (Fu et al., 1999) , Ste20-like kinase (SLK) (Ellinger-Ziegelbauer et al., 2000) , Prostate-derived Ste20-like Kinase (PSK) (Moore et al., 2000) , Kinase From Chicken (KFC) (Yustein et al., 2000) , Misshapen/NIKs-related kinase (MINK) (Dan et al., 2000) and NIK-like embryo speci®c kinase (NESK) are all known activators of JNK. By contrast, overexpression of the JNK-inhibitory kinase (JIK) (Tassi et al., 1999) leads to an inhibition of JNK activation. Not all GCK family members are involved in modulating the activity of JNK/SAPK. MST3 and STE20/SPS1-related proline alanine-rich kinase (SPAK), for instance, respectively activate p42/44 ERK and p38 MAPK, but not JNK (Johnston et al., 2000; Zhou et al., 2000) . There are also GCK members including Ste20/oxidant stress response kinase-1 (SOK-1) (Pombo et al., 1996 (Pombo et al., , 1997 , lymphocyte-oriented kinase (LOK) (Endo et al., 2000; Kuramochi et al., 1997) , and Proline-and alanine-rich Ste20-related kinase (PASK) (Tsutsumi et al., 2000) , which do not activate any of the known MAPK pathways. These observations suggest that Ste20 family of kinases have diverse functions and most, but not all, are involved in the modulation of MAPK family kinases.
While the signal pathways following kinase activations have been elucidated for many members of the Ste20 family kinases, we know much less about their biological eects on cells. Several recent reports implicate Ste20 family kinases in the apoptosis pathway (for a review see Dan et al., 2001) . This is perhaps understandable, since JNK and p38MAPK, two kinases involved in apoptosis are downstream targets of many of these Ste20 kinases (for a review see . It was shown that MST1, which activates JNK and p38MAPK, induces apoptosis when overexpressed in cells or when cells were treated with Fas or staurosporine (Graves et al., 1998; Lee et al., 1998) . The activity of MST1 is enhanced by caspase 3 cleavage, and, in turn, the active MST1 is capable of activating caspase 3. Likewise, HPK1 and SLK have also been reported to be activated by caspase 3 cleavage during Fas mediated apoptosis Sabourin and Rudnicki, 1999; Sabourin et al., 2000) . The resulting kinase domain has an enhanced potential to activate JNK pathway Sabourin and Rudnicki, 1999; Sabourin et al., 2000) . These observations also extend to the PAK subfamily of kinases; PAK2 is activated by caspase cleavage during Fas-and TNFa-induced apoptosis, and the cleaved kinase domain induces formation of apoptotic bodies (Rudel and Bokoch, 1997) . PAK1, on the other hand, has the potential to prevent apoptosis by phosphorylating Bad (Schurmann et al., 2000) . The above ®ndings suggest a role of Ste20 family kinases in the modulation of apoptosis pathway. Relatively little is known about the involvement of Ste20 kinases in cellular growth and transformation. Recently, Vadlamudi et al. (2000) reported that activated PAK1 induces anchorageindependent growth of human epithelial breast cancer cells and Yustein et al. (2000) showed chicken embryo ®broblasts overexpressing KFC, a GCK-subfamily kinase, exhibit enhanced growth rate. In both cases, the activation of MAPK family kinases accompanies the growth stimulation.
In the present study, we cloned and characterized a human protein kinase representing a new member of the Ste20-related kinase family. Database searches revealed that this novel kinase has the highest homology to MST3 kinase. Thus, we designate this kinase, MST4. MST4 mRNA can be detected in several tissues and is highly expressed in thymus, placenta and peripheral blood leukocytes. We present evidence that MST4 speci®cally activates ERK, but not JNK and p38 MAPK. This activation is via MEK1 but independent of Ras/Raf. Importantly, we provide evidence that MST4 is able to stimulate cell growth and mediate anchorage-independent transformation of human epithelial cell lines.
Results

Cloning of MST4
The full-length MST4 cDNA was cloned by digital cloning strategy we previously developed (Chen et al., 1998) . Brie¯y, to search novel protein kinases, six 15-mer peptide sequences derived from human PAK1 kinase, CDK kinase, ERK1 kinase, YAK1 kinase, PKA kinase and PKC kinase were designed and used as peptide probes to search the EST data base maintained in the National Center for Biotechnology Information. Several EST clones corresponding to this gene were identi®ed. RT ± PCR and DNA sequencing analysis were performed to con®rm the existing cDNA for the novel kinase. The missing 5' and 3' portions were obtained by RACE. We used the total RNA from HR cells (a gastric cancer cell line) as a template to obtain the full-length MST4 clone since HR cells express a relatively high level of MST4 transcript (data not shown). Sequencing of the MST4 RACE clone revealed a protein of 416 amino acid residues with a molecular mass of approximately 46 kDa (Figure 1a ). Blast search of GeneBank and EMBL database identi®ed a serine/threonine kinase domain (Hanks and Lindberg, 1991; Hanks and Quinn, 1991) at the amino-terminal region (amino acid residues 18 ± 300) with homology to members of the Ste20-like kinase family. The highest homology is with MST3 ( Figure  1b ): MST4 shares 88% identity in the kinase domain and 66% overall identity. Figure 1c showed a dendrogram illustrating the evolutionary relationship between MST4 and other members of the Ste20-like kinases. The genomic sequence comparison suggests that the MST4 gene is located on chromosome Xq25-26.3 region with at least 11 exons.
Expression pattern of MST4 mRNA
The expression pattern of MST4 transcript was examined by human multi-tissue Northern blot. As shown in Figure 2 , a major band of 3.6 kilobase pairs was detected. MST4 is ubiquitously expressed, with higher levels of message detected in placenta, thymus and peripheral blood leukocytes. By contrast, the expression level of MST4 in brain, heart, skeletal muscle and colon is low. MST4 expression was also detected in cancer cell lines including HeLa (cervical cancer cell line), HR (gastric cancer cell line), SK-Hep1 (hepatoma cell line) and Huh7 (Hepatoma cell line) cell lines via RT ± PCR (data not shown).
Identification and characterization of the human MST4 kinase
To generate antibody against MST4, we used GST fusion protein containing the carboxyl region of MST4 as an antigen to immunize rabbits. The speci®city of the antibody was tested by Western blot analysis of MST4 immunoprecipitated with the T7 tagged antibody. MST4 anti-serum, but not preimmune serum, recognized a speci®c band (*46 kDa) which comigrated with a band detected by anti-T7 antibody ( Figure 3a , lanes 2 and 4), attesting to the speci®city of the antibody. Using this antibody, we examined the protein expression pattern of MST4 among various cancer cell lines. As shown in Figure 3b , MST4 is highly expressed in SK-Hep1, Jurkat and HR cells. Lower expression was seen in HeLa and no expression was detected in Phoenix (a 293 T derived cell line), and hepatoma cell lines, Tong, HA22T and PLC5.
We next performed immunostaining to examine the subcellular localization of MST4 protein. As illustrated in Figure 4 (left column) overexpressed T7-tagged MST4 protein was detected in cytoplasm of Phoenix cells by MST4 antibody. Note that parental, untransfected cell did not give any signal in this staining, indicating the speci®city of MST4 antibody. Since HR cells express a higher level of MST4, we also examined the distribution of endogenous MST4. As shown in Figure 4 (right column) the majority of the MST4 immunostaining is again localized in cytoplasm with some weak staining in the nuclei. Thus, MST4 seems to be primarily localized in the cytoplasm.
We then sought to determine whether MST4 has intrinsic kinase activity. Endogenous MST4 was immunoprecipitated from HeLa cells with MST4 antibody and subjected to an in vitro kinase assay using myelin basic protein (MBP) as a substrate. Cell lysates immunoprecipitated by MST4 antibody, but not by preimmune serum, were able to phosphorylate MBP (Figure 5a ), indicating that MST4 is associated with a kinase activity. To more de®nitely demonstrate that the kinase activity comes from MST4 itself and not from an associated kinase, a kinase-dead mutant T7-MST4 KR was constructed. T7-MST4 KR has a T7 tag at its amino Bottom panel, the same ®lter was also subjected to Northern blot analysis with g-actin as a probe which demonstrated equal loading of RNA from dierent tissues terminus and is defective in ATP binding due to the conversion of lysine residue 53 to arginine. Cells transfected with this kinase-dead mutant were subjected to the immunoprecipitated kinase assay as before. Wild-type T7-tagged MST4 was used as a positive control. Cell lysates carrying wild-type T7-tagged MST4 eectively phosphorylated MBP in vitro, whereas no phosphorylation of MBP was observed with cell extracts containing the kinasedead mutant (Figure 5c (bottom panel) lanes 2 and 4). These ®ndings provide strong evidence that the activity detected from the wild-type MST4 is derived from its intrinsic kinase and not to a co-precipitated kinase. To further examine whether the carboxyl region of MST4 aects its kinase activity, a deletion mutant T7-MST4DC (deletion of 301 ± 416 amino acids) was tested in the in vitro kinase assay. As illustrated in Figure 5c (lane 3), deletion of this region did not signi®cantly alter MBP phosphorylation, indicating that the carboxyl domain is not critical for its enzymatic activity.
MST4 modulates ERK kinases activity
To explore whether MST4 is involved in regulating known MAPK pathways, we tested the eect of overexpressed MST4 on the activation of JNK, p38, and ERK pathways. As shown in Figure 6a , overexpressed MST4 failed to activate JNK activity, based on in vitro kinase assay of HA-JNK using GST-c-jun as a substrate. Positive control was provided by an constitutively active form of MEKK1. Similarly, MST4 overexpression showed no signi®cant eect on the activation of p38 MAPK (Figure 6b ). By contrast, MST4 signi®cantly increased the ERK activity, although the level is less than that conferred by constitutively active form of MEK1 (Figure 6c , lanes 2 and 3). The activation of ERK by MST4 is kinase activity-dependent, since no activation was observed by the MST4 KR mutant. These results suggest that overexpressed MST4 can speci®cally activate ERK kinase, but not JNK or p38 MAPK. 
MST4 activates ERK via MEK1 but not Ras/Raf
To explore the pathway by which MST4 activates ERK, a reporter gene assay of ERK dependent Elk1 activation was used. A reporter gene driven by Elk1-dependent promoter was transiently transfected into Phoenix cell lines stably overexpressing MST4 or its kinase-dead KR mutant. Consistent with the above results, overexpressed MST4 conferred sixfold activation of the reporter gene, whereas MST4 KR mutant only yielded a twofold induction (Figure 7a , lanes 2, 7 and 11). This activation was abolished by PD98059, an inhibitor of MEK1, in a dose-dependent fashion, but not by SB202190, a p38 inhibitor (lanes 7 ± 10). These ®ndings suggest that MST4-ERK pathway is mediated by MEK1. To further substantiate this result, a dominant negative (DN) MEK1 was transfected into MST4 stable cells and the ERK-activation of ELK1 was measured. In accordance with the result of PD98059 treatment, MEK1-DN can block the ERK activity induced by MST4 (Figure 7b , lanes 10 and 13). To study whether MEK1/ERK activation by MST4 is mediated through Ras and Raf, dominant negative mutant of Ras or Raf was included in this assay; Figure 5 Kinase activity of MST4. (a) kinase activity of endogenous MST4. HeLa cell lysate was precipitated by either preimmune serum or MST4 antibody. The immunoprecipitated complex was divided into two portions. One was for Western blot analysis with anti-MST4 antiserum (top panel). The other portion was subjected to in vitro kinase assay using [g-32 P]ATP and MBP as a substrate (Materials and methods). The reaction products were separated by SDS ± PAGE and subjected to autoradiography (bottom panel). (b) a schematic diagram of MST4 and its mutants. MST4 wild-type (WT) and its various mutants including c-terminus deletion (WTDC), kinase dead mutant (K53R), and K53R with c-terminus deletion (KRDC) were fused to a T7-tag expression vector. K53R is a kinase inactive mutant, in which the critical lysine (amino acid 53) required for ATP-binding has been changed to an arginine. The kinase domain is draw as black box and the T7 tag are indicated by dot box. (c) kinase activity of MST4 and its mutants. Phoenix cells were transfected with various MST4 constructions and cell lysate were subjected to immunoprecipitation assay and Western blot analysis with anti-T7 antibody (upper panel). After immunoprecipitation, in vitro kinase assay was performed (lower panel) using MBP as a substrate. The resulting reactions were subjected to SDS ± PAGE and autoradiography both failed to eectively block the MST4 mediated ERK activation. At the same time, both mutants diminished the EGF-induced ERK activation ( Figure  7b , lanes 4 ± 6). Taken together, these ®ndings suggest that MST4 activates MEK1-ERK signaling cascade in a Ras/Raf-independent fashion.
Overexpression of MST4 induces cellular growth
To explore the biological eect of MST4 on cell growth and transformation, we established stable clones of Phoenix and HeLa cells overexpressing MST4 wild-type or KR mutant. We chose Phoenix and HeLa cells for studies because of their undetectable or low MST4 expression level. To avoid clonal eect of stable cells, studies were carried out with a pool of more than 20 single clones, shown to express T7-tagged MST4 wild-type or KR mutant (data not shown). Immunocomplex kinase assay revealed that the precipitated MST4 from cells expressing wild-type kinase has the ability to phosphorylate MBP in vitro (Figure 8a, lane 3) , consistent with that of the transient expression studies. In addition, the kinase activity of wild-type MST4 could be further enhanced upon serum stimulation (lane 7), indicating that MST4 may mediate serum-induced cellular processes such as cellular growth. To explore this possibility, the growth of these cells was compared to that of the parental cell line or cell lines harboring the kinase-dead mutant. As shown in Figure 8b , overexpression of the wild-type MST4 leads to enhanced growth of the Phoenix cells, detectable by days 3 and 5. The KR mutants failed to do so. This is especially evident, when cells were cultured in low serum media (1%). This observation is interesting, as most of the other Ste-20 family kinases characterized prior to the present study do not induce cell growth. Our observation is however consistent with the ®nding that constitutive activation of MEK1 results in cell proliferation (Greulich and Erikson, 1998) .
Overexpression of MST4 confers cellular transformation
We next explored whether MST4 can potentiate cell transformation. MST4 wild-type and KR mutant stable clones were subjected to anchorage-independent growth (AIG) assay. Remarkably, overexpressed MST4 in Phoenix cells resulted in increased number as well as the size of the colonies in soft agar (Figure 9a ). The colony number was counted and summarized in Figure  9b . The MST4 induced colony formation in AIG assay can be blocked by PD98059, but not SB20219 ( Figure  9b ). These ®ndings reinforce the view that MST4 exerts its eect through the activation of ERK signaling pathway. The similar ®ndings were obtained in HeLa MST4 stable clones (Figure 9c ), indicating that the biological eect of MST4 is not cell type speci®c.
Discussion
By digital cloning, we have identi®ed a novel Ste20-related kinase, which, when overexpressed, can activate ERK pathway, resulting in cell growth and transformation. We also showed that MST4 speci®cally activates ERK, but not JNK and p38 (Figure 10 ). This 5 cells/well of each Phoenix stable cell line including pcDNA-T7 empty vector, T7-MST4 wild-type and KR mutant were transfected with CMV-b-galactosidase and GALluciferase reporter plasmid and various expression vectors as indicated by lipofectamine. After 24 h, cell lysates were collected, and the luciferase assay was performed (see Materials and methods). The relative activity was normalized to relative luciferase activity of vector stable cell transfected with Gal4 DBD (lane 1). ELK1 represents the Gal4-ELK1 fusion expression vector. Vector stable clone, wild-type MST4, and KR mutant stable clone were treated with MEK1 speci®c inhibitor PD98059 (2 or 20 mM) (lanes 4, 5, 8, 9, 12 and 13) or p38 MAPK inhibitor SB20219 (10 mM) (lanes 6, 10 and 14). As a positive control for ERK activation, vector stable clone was co-transfected with MEK1 (100 ng) (lane 3). B, MST4 stable clones were cotransfected with 1 mg of dominant negative Ras (Ras-DN) (lanes 5 and 11), Raf-DN (lanes 6 and 12), and MEK1-DN (lanes 7 and 13). The reporter assays were performed after EGF (10 ng/ml) treated for 12 h (lanes 4 ± 7). The experiments have been repeated at least four times activation requires MEK1, as both PD98059 and MEK1 DN mutant block the ERK activation induced by MST4. The molecular mechanism whereby MST4 transduces the signal to MEK1 is currently unknown. Based on the studies using Ras or Raf DN mutants, we know that Ras and Raf are not involved. Also not clear is the upstream signals that may modulate MST4 activity. In this study, we used overexpressed MST4, which appears to exhibit kinase activity without additional ligand activation. It is possible that endogenous MST4 may require an upstream signal for activation. Indeed, the kinase activity of MST4 can be further increased upon serum stimulation. Accumulating evidence indicate that Ste20 kinases may be involved in transmitting signals from cell surface receptors to the MAPK cascades. For instance, GCK functions as a molecular bridge linking TRAF2 and TNF type-1 receptor signaling complex to MEKK1-SEK1-JNK signaling pathway . Nck interacting kinase (NIK) has been shown to couple Eph receptors to JNK pathway via Nck (Becker et al., 2000) . Recent study demonstrated that kinase activity of HPK1 can be induced upon TCR/CD3 stimulation in Jurkat T cells and several proteins (Nck, LAT, and Crk) may be involved in linking HPK1 activation to T-cell (Ling et al., 2001) . MST4, likewise, may link a cell surface receptor to MEK1/ERK. To explore this possibility, we have surveyed several growth factors that might stimulate MST4 kinase activity. Preliminary data indicate that one of the agonists which activate MST4 is EGF (unpublished data).
In addition to the activation of ERK pathway, we showed that overexpression of wild-type MST4 also promotes cell proliferation and anchorage-independent growth. While kinase-dead MST4 failed to completely block these eects, it diminished the ELK-mediated reporter gene expression and anchorage-independent growth of cells (Figures 7a and 9) . We do not know why MST4 kinase-dead mutant does not fully reverse the transformation phenotypes, it is possible the biological functions of MST4 are not all kinasedependent. One pertinent precedent is TNIK kinase (Fu et al., 1999) , whose kinase-dead mutant is still capable of activating downstream signaling pathway. We found that MST4 is capable of dimerizing with itself (unpublished data) and it is possible that kinase dead mutant can activate endogenous MST4 or downstream signaling molecules through protein ± protein interactions.
Previous studies by others showed that expression of a constitutively activated MEK1 induce in NIH3T3 cells morphological changes, anchorage-independent growth and accelerated S phase entry (Blalock et al., 2000; Brunet et al., 1994; Greulich and Erikson, 1998; Ljungdahl et al., 1998; Rimerman et al., 2000; Schramek et al., 1997) , phenotypes similar to cells overexpressing MST4. Likewise, constitutively active ERK was shown to be sucient to elicit cell transformation (Greulich et al., 1996; Huang et al., 1999; Plattner et al., 1999; Verheijen et al., 1999) . These ®ndings are in good agreement with our results that MEK1/ERK activation by MST4 is the underlying cause of cellular transformation induced by MST4. The downstream target genes mediating the cell cycle progression and transformation are currently unknown, although activation of MEK/ERK pathway is linked to cell cycle progression by transcriptional elevation of cyclin D1 levels in G1 phase (Cheng et al., 1998; Greulich and Erikson, 1998; Lavoie et al., 1996) .
Our ®ndings that overexpressed MST4 can reduce the serum requirement for cell growth and anchorage independent growth may shed some lights on the biological roles of MST4 in cell proliferation and cancer formation. MST4 is highly expressed in poorly dierentiated hepatoma cell SK-Hep1 but not expressed in relatively dierentiated hepatoma cells (Tong, HA22T and PLC5). While not conclusive, these ®ndings suggest that MST4 expression may be related to the dierentiation state of the cancer cells. Further investigation is required to support this notion. To explore the correlation between MST4 expression and cancer formation, we have examined its expression Figure 8 Overexpressed MST4 enhances cell growth. (a) Serum induces the kinase activity of MST4 stable clones. Cell lysates from serum-starvation for 24 h or serum-stimulation for 30 min of Phoenix cells, empty vector stable clone, MST4 wild-type and KR mutant stable clones were subjected to immunoprecipitation assay with anti-T7 antibody and followed by in vitro kinase assay. Cell lysates were also separated by SDS ± PAGE and immunoblotted with anti-T7 antibody (bottom panel). (b) Each stable clone was seeded 500 cells into 6-cm dish in culture media containing dierent serum concentrations (1 or 10%) as indicated. Cells were harvested on days 1, 3 and 5 followed by Trypan blue staining for viable counting. The cell count is based on four independent experiments level in several gastric tumor tissues and colon cancer tissues (cancer versus adjacent normal tissues from the same patient). The preliminary results indicate that MST4 has elevated expression in cancer tissue (unpublished data).
Among the Ste20 family kinases, MST3 shares the highest homology with MST4. While the biological functions of MST3 remains to be de®ned, MST3 was shown to activate ERK in HEK293 cells, consistent with the data reported here for MST4 (Zhou et al., 2000) . It should be noted that while the kinase domain between MST3 and 4 share a high degree of homology, the carboxyl terminal domains for these two kinases are entirely dierent. For GCK class of Ste20 kinases, the carboxyl-terminal domain often serves a regulatory function in kinase activity. Thus, removal of the carboxyl-terminal domain of KFC and MST1 unleashes the kinase activity (Creasy et al., 1996; Yustein et al., 2000) . This however does not seem to be the case for MST4, as the C-terminal truncated MST4 displays a similar level of kinase activity as the wild-type. Another common means of regulating the Ste20 kinase activity is by caspase cleavage. MST1, MST2, HPK1, SLK and PAK2 have been reported to be cleaved by caspases (Arnold et al., 2001; Graves et al., 1998; Lee et al., 1998 Lee et al., , 2001 Sabourin et al., 2000) . The caspase cleavage leads to increased kinase activity with the consequent activation of JNK (Arnold et al., 2001; Graves et al., 1998 Graves et al., , 2001 or p38 MAPK (Graves et al., 1998; Kakeya et al., 1998) to promote apoptosis. Inspection of amino acid sequences of MST4 reveals a putative caspase 3-like protease cleavage site (DESD 305 S) which is adjacent to the carboxyl end of kinase domain. At least in vitro, we failed to demonstrate cleavage of MST4 by caspase 3, 6 or 7 (unpublished data). The mode of regulation of MST4 thus remains to be determined.
After completion of this manuscript, we saw an in press report of Qian et al. (2001) who described the identi®cation and biochemical characterizations of MST4. Their results are generally in good agreement with ours. Our report, however diers from theirs by at least two important aspects. First, Qian et al. (2001) failed to detect the activation of the MEK-ERK Figure 9 Overexpressed MST4 potentiates anchorage independent growth. (a). Phoenix cells, empty vector stable clone, MST4 wild-type and KR mutant stable clones were subjected to anchorage-independent growth assay. Ten thousand cells were embedded into medium containing 0.3% agarose and cultured in regular medium. The culture medium was changed every 3 days. After 3 weeks, anchorage independent growth colonies were observed under microscope (top panel). Bar length represents 100 mm. The culture plates from each stable clone were further stained with 0.1% crystal violet dye (bottom panel) and then counted for larger than 0.1 mm by b and c, during the anchorage independent growth assay of Phoenix (b) or HeLa (c) stable clones, the culture cells were treated with PD98059 (2 mM) or SB20219 (2 mM) when culture medium was changed. After 3 weeks, the amount of colonies was counted and plotted to the barograph. The colony number is based on three independent experiments pathway by MST4. This is most likely due to the dierent cell lines used, although in our hands, two dierent cell lines understudy showed ERK activation by MST4. Second, we ascribe the ®rst biological function for MST4 and show its involvement in cell growth and transformation.
Materials and methods
Cell cultures
Phoenix, HeLa, Jurkat, and several hepatoma cell lines (Tong, PLC5, HA22T, and SK-Hep1) were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (Life Technologies, Inc.). HR cells, a gastric cancer cell line, were cultured in RPMI 1640 culture medium (Life Technologies, Inc.). Both media were supplemented with 10% FBS, 16nonessential amino acids, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Phoenix cells were also transfected with dierent human MST4 constructs and stable transfectants were isolated by selection in G418 (1 mg/ ml) and regularly maintained in selected medium containing G418 and replaced medium every 3 ± 4 days.
Cloning of MST4-and plasmid constructs
The full-length MST4 cDNA was cloned by digital cloning strategy which has been described (Chen et al., 1998) . For novel EST clones homologous to protein kinase, six 15-mer peptide sequences derived from human PAK1 kinase, CDK kinase, ERK1 kinase, YAK1 kinase, PKA kinase and PKC kinase were designed and used as peptide probes to search the EST data base maintained in the National Center for Biotechnology Information. Several EST clones which indicate the same gene by their overlapped nucleotide sequences were assembled. RT ± PCR and DNA sequencing analysis were performed to con®rm the existing cDNA for the novel kinase. Missing 5' and 3' portions were obtained by RACE. We used the total RNA from HR cells to get the fulllength MST4 since HR cells conferred a higher content of MST4 messenger. Total RNA from HR cells was isolated using Trizol (Life Technologies, Inc.) and followed by reverse-transcribed to cDNA using high ®delity Taq polymerase (Roche) primed with oligo(dT)17. PCR was performed using two primers 5'-GCGGTACCATGGCTA-GCATGACTGGTGGACAGCAAATGGGTTCCGAGGG-CTCTGATTCGGAATCTACC and 5'-GGGGTACCGGG-GATCTAGATCTTAAAAGCAAAACGGTG. The fulllength MST4 cDNA was subcloned into pcDNA 3.0 expression vector with T7-tag at its N-terminal. T7-tag MST4 DC mutant (1 ± 300 amino acids containing kinase domain) and MST4 K53R kinase dead mutant were generated by PCR and site directed mutagenesis, respectively.
Northern blot analysis
cDNAs of MST4 (nucleotides 900 ± 1251) and the human gactin were labeled with a-32 P-dCTP using a random priming kit (Amersham). The labeled probes were used in Northern blot analysis with commercial human multiple tissue Northern blot (Clontech). Hybridization was performed as recommended by the manufacturer. After prehybridization, hybridization and highly stringent washing, the membrane was exposed to phosphoimager and analysed by Bio-imaging Analyser BAS1500 (Fuji).
In vitro kinase assay
The expression vectors of T7 MST4 wild-type (WT), KR, WTDC, and KRDC were transfected into Phoenix cells by lipofectamine (GIFCO). After 48 h, cells were lysed in lysis buer containing 20 mM Tris-HCl (pH 8.0), 0.5% Nonidet P-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM DTT, 0.5 mM phenylmethylsulfony¯uoride (PMSF), 20 mM bglycerolphosphate, 1 mM sodium orthovanadate and 1 mg/ ml leupeptin. Cell lysates were precleared with protein ASepharose (Calbiochem) for 1 h and then incubated with anti-T7 monoclonal antibody (Novagene) for 2 h at 48C. The immune complexes were precipitated with protein A-sepharose, washed three times with lysis buer, and then washed three times with kinase buer containing 20 mM HEPES pH 7.5, 20 mM b-glycerophosphate, 10 mM MgCl 2 , 1 mM NaF, 1 mM NaVO 4 , 0.5 mM dithiothreitol. To perform the kinase reaction, the immunoprecipitates were incubated with 50 mM cold ATP and [g-32 P]ATP with substrate, myelin basic protein (MBP) for 30 min at 258C. The reaction products were subjected to 10% SDS-polyacrylamide gel electrophoresis. The gels were ®xed, dried, and autoradiographed.
Preparation of polyclonal antibody
The GST-MST4-C plasmid was constructed by inserting a MST4 DNA fragment coding amino residues from 302 ± 416 into the pGEX4T-3 expression vector (Pharmacia). The GSTfusion proteins was expressed in Escherichia coli BL21 in the presence of 0.5 mM isopropyl-1-thio-b-galactopyranoside, Figure 10 Summary of MST4 signaling pathway. A scheme diagram is provided to illustrate the MST4 in activation of MEK1/ERK pathway, resulting in growth induction and cellular transformation. The activation of MEK-1/ERK by MST4 is Ras/ Raf independent. MST4 fails to activate either JNK or p38 MAPK pathway puri®ed and used to immunize rabbits. Polyclonal antibody was anity-puri®ed using GST-MST4-C proteins bound to CNBr-activated Sepharose 4B (Pharmacia). The antibody was used in detecting MST4 in Western blotting and immunostaining analysis.
Immunohistochemical staining
To examine the subcellular localization of MST4, the polyclonal antibody against GST-MST4C was utilized in the immunostaining of the T7-MST4-transfected cells and non-transfected HR cells (for endogenous MST4). In brief, T7-MST4 transfected Phoenix cells or HR cells were plated on cover slide glasses and cultured in medium. After 48 h transfection, cells were ®xed for 10 min in 4% paraformaldehyde and then incubated with MST4 polyclonal antibody, followed by adding the secondary antibody conjugation with TRITC. DAPI was used to stain nucleus. The results were photographed by a¯uorescence microscope.
Assays of the JNK/SAPK, p38 and p42/44 MAP kinases activation
To examine the MAPK activation in response to the overexpression of MST4, Phoenix cells were cotransfected with either wild-type or kinase dead mutant T7-MST4 along with dierent MAPKs (HA-JNK, Flag-p38, His-ERK). The JNK activity was analysed by in vitro kinase assay. Brie¯y, cell lysates containing HA-JNK were immunoprecipitated with anti-HA antibody (BAbCO) and followed by in vitro kinase assay with GST-jun (New England Bio-lab) as a substrate. For p38 MAPK activation, cell lysates containing Flag-p38 were immunoprecipitated with anti-Flag antibody (M2) and subjected into Western analysis. The activated p38 was detected by a speci®c phospho-p38 MAPK antibody which can recognize the phosphorylated threonine 180 and tyrosine 182 of p38 MAPK (New England Bio-Labs.). For p42/44 MAPK activation, cell lysates were immunoprecipitated with a speci®c antibody against phospho-p42/44 MAPK (New England Bio-Labs.), following by Western blot analysis with p42/44 MAPK antibody.
Soft agar colony formation assay
Phoenix cells, HeLa cells, and cells stably expressing MST4 wild-type or kinase dead proteins were trypsinized, diluted in 0.3% of top agar and plated onto 60-mm dishes with 0.5% of bottom agar. Ten thousand cells were seeded in each plate. Plates were incubated at 378C for 3 weeks. Colonies were visualized by staining with 0.05% p-iodonitrotetrazolium violet dye and then colonies larger than 0.1 mm were counted by AIS image analysis system (Imaging Res. Inc.). Each experiment was repeated four times. The average and the standard error of the mean are shown in a barograph.
Luciferase reporter assay
Phoenix and various MST4 stable cells were transfected with CMV-b-galactosidase, 56gal-luciferase reporter gene and expression vector of Gal4-ELK1, Gal4-DBD, constitutively active MEKK1, MEK1 and MEK3 (from Stratagene) as indicated in Figures. Cells were transfected for 20 h and then serum starvation for 24 h followed by harvested cell lysates with lysis buer as described above. The lysates were collected and the relative luciferase activity (®re¯y luciferase for reporter and b-galactosidase activity for normalization of transfection eciency) was measured as manufacturer's instructions (LucLite, Packard). Each experiment was repeated at least three times.
